SOA Wealth Advisors’s Zomedica Corp. ZOM Stock Holding History

SOA Wealth Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,084	Closed	-$158	–	928
2024 Q1	$158	Hold	1,084	–	–	﹤0.01%	857
2023 Q4	$217	Hold	1,084	–	–	﹤0.01%	847
2023 Q3	$181	Hold	1,084	–	–	﹤0.01%	881
2023 Q2	$217	Hold	1,084	–	–	﹤0.01%	877
2023 Q1	$229	Hold	1,084	–	–	﹤0.01%	895
2022 Q4	$177	Hold	1,084	–	–	﹤0.01%	914
2022 Q3	$0	Hold	1,084	–	–	﹤0.01%	1037
2022 Q2	$0	Hold	1,084	–	–	﹤0.01%	1086
2022 Q1	$0	Buy	+1,084	New	+$355	﹤0.01%	1039

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

SOA Wealth Advisors's ZOM Position: Q2 2024 in Review

SOA Wealth Advisors sold out of Zomedica Corp. (ZOM) in Q2 2024, closing a stake of 1,084 shares — an estimated $158 sold.

SOA Wealth Advisors first reported a position in ZOM in Q1 2022 and held it in 9 quarters. The position peaked at $229 in Q1 2023. 96 funds tracked by Wall St. Rank hold ZOM as of Q2 2024.

SOA Wealth Advisors reported no remaining Zomedica Corp. position as of Q2 2024 after selling out during the quarter.
SOA Wealth Advisors sold 1,084 Zomedica Corp. shares in Q2 2024, an estimated $158.
SOA Wealth Advisors first reported a position in Zomedica Corp. in Q1 2022 and held it in 9 quarters.
SOA Wealth Advisors's Zomedica Corp. position peaked at $229 in Q1 2023.
96 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2024.

Based on SOA Wealth Advisors's 13F filing for Q2 2024, filed 17 Jul 2024.